Isabel Villaoslada

ALK signaling drives tumorigenicity and chemoresistance of pancreatic ductal adenocarcinoma cells

C. Heeschen, K. Olive, B. Parejo-Alonso, 2022, bioRxiv.

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?

M. Gaboli, O. Neth, P. Olbrich, 2021, Journal of Clinical Immunology.

Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations

J. Milner, A. Freeman, M. Lionakis, 2022, Journal of Clinical Immunology.

Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma.

C. Heeschen, K. Olive, P. Sancho, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant

J. Casanova, A. Puel, W. Lei, 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.